Chen Chang
State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma.
Journal: Translational oncology
Published: September 03, 2023
Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC.
Journal: Translational oncology
Published: September 11, 2022
NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Journal: Yi chuan = Hereditas
Published: April 19, 2022
Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling.
Journal: Biochemical and biophysical research communications
Published: February 17, 2022
Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
Journal: Journal of clinical laboratory analysis
Published: March 17, 2021
Prognostic role of aberrant mTOR activation in patients with stage II and III colorectal cancer.
Journal: Biomarkers in medicine
Published: September 24, 2020
Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.
Journal: OncoTargets and therapy
Published: May 28, 2020
The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
Journal: Cell death & disease
Published: December 23, 2019
PIK3CA mutations and downstream effector p-mTOR expression: implication for prognostic factors and therapeutic targets in triple negative breast cancer.
Journal: International journal of clinical and experimental pathology
Published: April 03, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026